biotech
Bio-AnalystSupplement research
person

Psyllium

Selected research topic

Blood lipids

Findings differ across measurements or study conditions. The results below keep them separate.

Findings from a combination study cannot be attributed to this ingredient alone.

Some findings concern patients or people with a deficiency.

Publications for this topic
23
Human comparison publications
8
Publications needing review
11

Findings in the studies

  • LDL cholesterol

    Human comparison research
    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
    • A better result than the comparison group was reported.
      Patient group · Separable contribution · 8 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Separable contribution
      How results were compared
      Results were compared between groups. · Study comparison: 10 mg simvastatin plus psyllium versus 10 mg simvastatin plus placebo
      Additional measurement information
      Primary outcome
      Measurement time
      8 weeks
    • A better result than the comparison group was reported.
      Patient group · Single ingredient · 8 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Between-group comparison
      Additional measurement information
      Primary outcome
      Measurement time
      8 weeks
    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Combination study
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Ingredient combination
      Measurement time
      Not confirmed.
  • plasma LDL-cholesterol concentration

    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
  • ratio of total cholesterol to high-density lipoprotein cholesterol

    • A better result than the comparison group was reported.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · 10 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Results were compared between groups. · Between-group comparison
      Additional measurement information
      Secondary outcome
      Measurement time
      10 weeks
  • serum total cholesterol

    Human comparison research
    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · after 3 months
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: within-group after-treatment change; no control group described
      Measurement time
      after 3 months
Other measured outcomes (4)
  • serum total, LDL, and HDL cholesterol

    • Results were mixed for this outcome.
      Patient group · Single ingredient · three 2-week periods
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: psyllium mixed with cereal versus wheat-bran control; between-meal psyllium versus control
      Additional measurement information
      Primary outcome
      Measurement time
      three 2-week periods
  • TC levels

    • A better result than the comparison group was reported.
      Patient group · Single ingredient · 3 months after dietary lead-in
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: psyllium plus phase I diet versus diet alone
      Additional measurement information
      Primary outcome
      Measurement time
      3 months after dietary lead-in
  • Serum cholesterol concentration

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.
      Single ingredient
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Single ingredient
      Measurement time
      Not confirmed.
  • Total cholesterol

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      General population · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: within-person timing crossover; no cholesterol-lowering vs baseline observed
      Additional measurement information
      Secondary outcome
      Measurement time
      8-week morning and evening periods

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (1)
  • Cholesterol · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Partial research summary

Human studies reported both between-group improvement and a change with no confirmed comparison group for LDL cholesterol.

These conditions come from related studies and may not describe a single paper.

single- and combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · Includes patient groups · Population not specified · between-group comparison · within-group comparison · comparator not confirmed

5 publications linked to this result (1 awaiting review included)

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
  • Some publications have not cleared source or interpretation review.
  • Some papers could not be reviewed, so this summary covers only findings that could be confirmed.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 65.0 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 84

Papers linked to this topic 23 · distinct papers 23 · papers with a confirmed human comparison 8 · papers needing additional review 11

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Cholesterol: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • LDL cholesterol: Sources represented in this measurement group: 5 · Distinct papers with human comparisons for this outcome: 3
  • plasma LDL-cholesterol concentration: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • ratio of total cholesterol to high-density lipoprotein cholesterol: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • Serum cholesterol concentration: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • serum total cholesterol: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 1
  • serum total, LDL, and HDL cholesterol: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • TC levels: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • Total cholesterol: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

serum total, LDL, and HDL cholesterol

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Total cholesterol

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL cholesterol

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL-C

The study reported improvement in this measurement.

Controlled study in people · Separable contribution · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL-C

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

plasma LDL-cholesterol concentration

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

ratio of total cholesterol to high-density lipoprotein cholesterol

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

serum total cholesterol

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TC levels

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

serum total cholesterol

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL cholesterol

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Serum cholesterol concentration

A change was reported, but the comparison could not be confirmed.

Other evidence · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cholesterol

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL-C

The study needs further checking before its result can be interpreted.

Controlled study in people · Separable contribution · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

5 papers · 5 measured outcomes

5 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

small bowel obstruction1 papers
Four patients experienced small bowel obstruction after oral psyllium seed husk use as a contrast agent.Human studies · Study type not identified
Intestinal obstruction1 papers
Psyllium ingestion without adequate fluids caused intestinal obstruction in a 21‑year‑old man.Human studies · Observational study